The stock of Cellebrite DI Ltd (CLBT) has seen a -2.91% decrease in the past week, with a -17.28% drop in the past month, and a -7.60% decrease in the past quarter. The volatility ratio for the week is 1.66%, and the volatility levels for the past 30 days are at 3.14% for CLBT. The simple moving average for the past 20 days is -6.30% for CLBT’s stock, with a -13.43% simple moving average for the past 200 days.
Is It Worth Investing in Cellebrite DI Ltd (NASDAQ: CLBT) Right Now?
Additionally, the 36-month beta value for CLBT is 1.32. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for CLBT is 108.96M and currently, short sellers hold a 1.66% ratio of that float. The average trading volume of CLBT on June 04, 2025 was 1.24M shares.
CLBT) stock’s latest price update
Cellebrite DI Ltd (NASDAQ: CLBT)’s stock price has increased by 1.90 compared to its previous closing price of 16.35. However, the company has seen a -2.91% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-20 that TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 20, 2025 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company plans to participate in the following investor conferences in May and June: Date: May 28, 2025 Conference: Craig-Hallum Institutional Investor Conference Format: 1×1 Meetings Only Cellebrite executives: Dana Gerner, chief financial officer Andrew Kramer, vice president, investor relations Date: May 29, 2025 Conference: TD Cowen 52nd Annual Technology, Media & Telecom Conference Presentation Time: 11:25 a.m.
Analysts’ Opinion of CLBT
Many brokerage firms have already submitted their reports for CLBT stocks, with Needham repeating the rating for CLBT by listing it as a “Buy.” The predicted price for CLBT in the upcoming period, according to Needham is $13.50 based on the research report published on March 28, 2024 of the previous year 2024.
BofA Securities gave a rating of “Buy” to CLBT, setting the target price at $12 in the report published on February 16th of the previous year.
CLBT Trading at -10.75% from the 50-Day Moving Average
After a stumble in the market that brought CLBT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.65% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CLBT starting from DAVID GEE, who proposed sale 12,150 shares at the price of $16.71 back on May 23 ’25. After this action, DAVID GEE now owns shares of Cellebrite DI Ltd, valued at $203,026 using the latest closing price.
DAVID GEE, the OFFICER of Cellebrite DI Ltd, proposed sale 10,555 shares at $17.05 during a trade that took place back on May 21 ’25, which means that DAVID GEE is holding shares at $179,963 based on the most recent closing price.
Stock Fundamentals for CLBT
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.84 for the gross margin
The net margin for Cellebrite DI Ltd stands at -0.71. The total capital return value is set at 0.14. Equity return is now at value -115.35, with -31.35 for asset returns.
Based on Cellebrite DI Ltd (CLBT), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at 12.05. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is 0.17.
Currently, EBITDA for the company is 67.51 million with net debt to EBITDA at -2.68. When we switch over and look at the enterprise to sales, we see a ratio of 9.49. The receivables turnover for the company is 4.87for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
In conclusion, Cellebrite DI Ltd (CLBT) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
